47LOW

EMV

EMVISION FPO [EMV]
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.
Healthcare · ASX Small Cap
$1.5500 -1.9%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical44
Catalyst55
Sentiment50
Fundamental70
Momentum51
Risk Gate50
Get alerts when EMV's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track EMV — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Adequate cash runway (8 quarters)
  • Moderate revenue growth (+11%)
  • EPS estimates revised upward (+6pts)
  • Near 52-week low (6% of range)
  • Sentiment is mixed — no strong consensus either way
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Deeply negative margins (-188%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • The bigger volume days are the down days — volume-weighted momentum is negative (-0.31%/day)
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about EMV
"What's driving EMV's score?" "How does EMV compare to peers?" "Key risks for EMV?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE $3.8m R&D Rebate Received & Overseas Finding Approved
NONE Update - S&P DJI March 2026 Rebalance of the All Ordinaries
NONE S&P DJI Announces March 2026 Quarterly Rebalance
Announcement tone +5pts

Recent ASX Announcements

2026-03-15 $3.8m R&D Rebate Received & Overseas Finding Approved PRICE SENSITIVE
2026-03-10 Update - S&P DJI March 2026 Rebalance of the All Ordinaries PRICE SENSITIVE
2026-03-06 S&P DJI Announces March 2026 Quarterly Rebalance PRICE SENSITIVE
2026-02-22 Half Yearly Presentation
2026-02-22 Half Yearly Report and Accounts PRICE SENSITIVE

Key Metrics

$144.1M
Market Cap
44K
Avg Volume
1.2x
Vol Ratio
$1.49 — $2.43
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-58.0%
ROE
-188.0%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 67%
LLeader vs LaggardlaggardRS: -3
IInstitutional SponsorshipweakInst: 3%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #56 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:EMV vs ATXEMV vs PNVEMV vs IMM
Scout Pro — Deeper Analysis for EMV
Try Pro free for 30 days
Share this analysis

Track EMV and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required